{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:45:29Z","timestamp":1783464329998,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00535-020-01714-7","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T14:02:36Z","timestamp":1596895356000},"page":"1087-1097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-7744","authenticated-orcid":false,"given":"Ahmad Hassan","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge D.","family":"Machicado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gage","family":"Buness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh T.","family":"Chari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"key":"1714_CR1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2018.06.082","volume":"155","author":"K Miyabe","year":"2018","unstructured":"Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and extra-intestinal manifestations of IgG4-related disease. Gastroenterology. 2018;155:990\u20131003 e1.","journal-title":"Gastroenterology"},{"key":"1714_CR2","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62:1607\u201315.","journal-title":"Gut"},{"key":"1714_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jhep.2014.04.016","volume":"61","author":"K Okazaki","year":"2014","unstructured":"Okazaki K, Uchida K, Koyabu M, et al. IgG4 cholangiopathy: current concept, diagnosis, and pathogenesis. J Hepatol. 2014;61:690\u20135.","journal-title":"J Hepatol"},{"key":"1714_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0016-5107(04)02229-1","volume":"60","author":"T Nakazawa","year":"2004","unstructured":"Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937\u201344.","journal-title":"Gastrointest Endosc"},{"key":"1714_CR5","first-page":"20","volume":"30","author":"T Nakazawa","year":"2005","unstructured":"Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20\u20135.","journal-title":"Pancreas"},{"key":"1714_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s00535-007-2038-8","volume":"42","author":"T Nishino","year":"2007","unstructured":"Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol. 2007;42:550\u20139.","journal-title":"J Gastroenterol"},{"key":"1714_CR7","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/j.1440-1746.2010.06411.x","volume":"25","author":"HC Oh","year":"2010","unstructured":"Oh HC, Kim MH, Lee KT, et al. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2010;25:1831\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"1714_CR8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982\u20134.","journal-title":"J Gastroenterol"},{"key":"1714_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706\u201315.","journal-title":"Gastroenterology"},{"key":"1714_CR10","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","volume":"4","author":"ST Chari","year":"2006","unstructured":"Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010\u20136 (quiz 934).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1714_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660\u201378.","journal-title":"Hepatology"},{"key":"1714_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist. 2016;21:594\u20139.","journal-title":"Oncologist."},{"key":"1714_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695\u2013706.","journal-title":"Stat Med"},{"key":"1714_CR14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.cgh.2018.02.049","volume":"16","author":"S Majumder","year":"2018","unstructured":"Majumder S, Mohapatra S, Lennon RJ, et al. Rituximab maintenance therapy reduces rate of relapse of pancreaticobiliary immunoglobulin G4-related disease. Clin Gastroenterol Hepatol. 2018;16:1947\u201353.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1714_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/ajg.2014.223","volume":"109","author":"MT Huggett","year":"2014","unstructured":"Huggett MT, Culver EL, Kumar M, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol. 2014;109:1675\u201383.","journal-title":"Am J Gastroenterol"},{"key":"1714_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-0036-1584320","volume":"36","author":"Y Nakanuma","year":"2016","unstructured":"Nakanuma Y, Ishizu Y, Zen Y, et al. Histopathology of IgG4-related autoimmune hepatitis and IgG4-related hepatopathy in IgG4-related disease. Semin Liver Dis. 2016;36:229\u201341.","journal-title":"Semin Liver Dis"},{"key":"1714_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","volume":"30","author":"H Chung","year":"2010","unstructured":"Chung H, Watanabe T, Kudo M, et al. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int. 2010;30:222\u201331.","journal-title":"Liver Int"},{"key":"1714_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/1756-185X.13093","volume":"20","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Song JJ, Park YB, Lee SW. Malignancies in Korean patients with immunoglobulin G4-related disease. Int J Rheum Dis. 2017;20:1028\u201335.","journal-title":"Int J Rheum Dis"},{"key":"1714_CR19","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3899\/jrheum.150436","volume":"42","author":"J Asano","year":"2015","unstructured":"Asano J, Watanabe T, Oguchi T, et al. Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J Rheumatol. 2015;42:2135\u201342.","journal-title":"J Rheumatol"},{"key":"1714_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/MPA.0000000000000312","volume":"44","author":"S Detlefsen","year":"2015","unstructured":"Detlefsen S, Mortensen MB, Pless TK, et al. Laparoscopic and percutaneous core needle biopsy plays a central role for the diagnosis of autoimmune pancreatitis in a single-center study from Denmark. Pancreas. 2015;44:845\u201358.","journal-title":"Pancreas"},{"key":"1714_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414\u20138.","journal-title":"Mod Rheumatol"},{"key":"1714_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000455963","volume":"95","author":"A Schneider","year":"2017","unstructured":"Schneider A, Hirth M, Munch M, et al. Risk of cancer in patients with autoimmune pancreatitis: a single-center experience from Germany. Digestion. 2017;95:172\u201380.","journal-title":"Digestion"},{"key":"1714_CR23","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771\u20136.","journal-title":"Gut"},{"key":"1714_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.pan.2016.02.006","volume":"16","author":"A Lopez-Serrano","year":"2016","unstructured":"Lopez-Serrano A, Crespo J, Pascual I, et al. Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: a multi-centre study. Pancreatology. 2016;16:382\u201390.","journal-title":"Pancreatology"},{"key":"1714_CR25","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39773","volume":"68","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Wallace CJ, Lu N, et al. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 2016;68:2283\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"1714_CR26","doi-asserted-by":"publisher","first-page":"6126707","DOI":"10.1155\/2017\/6126707","volume":"2017","author":"M Buechter","year":"2017","unstructured":"Buechter M, Manka P, Heinemann FM, et al. Outcome and genetic factors in IgG4-associated autoimmune pancreatitis and cholangitis: a single center experience. Gastroenterol Res Pract. 2017;2017:6126707.","journal-title":"Gastroenterol Res Pract"},{"issue":"920\u20136","key":"1714_CR27","first-page":"e3","volume":"15","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Tazuma S, Okazaki K, et al. Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis. Clin Gastroenterol Hepatol. 2017;15(920\u20136):e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1714_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-4933-5-11","volume":"5","author":"E Derhovanessian","year":"2008","unstructured":"Derhovanessian E, Solana R, Larbi A, Pawelec G. Immunity, ageing and cancer. Immun Ageing. 2008;5:11.","journal-title":"Immun Ageing"},{"key":"1714_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/MPA.0b013e3181b65a1c","volume":"38","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Tsuruta K, Okamoto A, et al. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas. 2009;38:890\u20135.","journal-title":"Pancreas"},{"key":"1714_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41598-018-37404-x","volume":"9","author":"Y Gion","year":"2019","unstructured":"Gion Y, Takeuchi M, Shibata R, et al. Up-regulation of activation-induced cytidine deaminase and its strong expression in extra-germinal centres in IgG4-related disease. Sci Rep. 2019;9:761.","journal-title":"Sci Rep"},{"key":"1714_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ajg.2012.465","volume":"108","author":"M Shiokawa","year":"2013","unstructured":"Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610\u20137.","journal-title":"Am J Gastroenterol"},{"key":"1714_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","volume":"19","author":"H Ohara","year":"2012","unstructured":"Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536\u201342.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1714_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732\u20138.","journal-title":"N Engl J Med"},{"key":"1714_CR34","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/hep.24487","volume":"54","author":"AM Oseini","year":"2011","unstructured":"Oseini AM, Chaiteerakij R, Shire AM, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 2011;54:940\u20138.","journal-title":"Hepatology"},{"key":"1714_CR35","doi-asserted-by":"crossref","first-page":"580814","DOI":"10.1155\/2012\/580814","volume":"2012","author":"Y Masaki","year":"2012","unstructured":"Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814.","journal-title":"Int J Rheumatol"},{"key":"1714_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2214\/AJR.12.10360","volume":"202","author":"A Tokala","year":"2014","unstructured":"Tokala A, Khalili K, Menezes R, et al. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. AJR Am J Roentgenol. 2014;202:536\u201343.","journal-title":"AJR Am J Roentgenol"},{"key":"1714_CR37","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1053\/j.gastro.2010.01.001","volume":"138","author":"SB Ko","year":"2010","unstructured":"Ko SB, Mizuno N, Yatabe Y, et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology. 2010;138:1988\u201396.","journal-title":"Gastroenterology"},{"key":"1714_CR38","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","volume":"101","author":"FD Mendes","year":"2006","unstructured":"Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070\u20135.","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-020-01714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T08:16:13Z","timestamp":1667722573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-020-01714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1007\/s00535-020-01714-7","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}